Barings’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q4
Sell
-2,590
Closed -$207K 684
2019
Q3
$207K Hold
2,590
﹤0.01% 626
2019
Q2
$202K Sell
2,590
-4,450
-63% -$347K ﹤0.01% 653
2019
Q1
$826K Hold
7,040
0.02% 433
2018
Q4
$767K Buy
7,040
+2,450
+53% +$267K 0.01% 429
2018
Q3
$587K Hold
4,590
0.01% 590
2018
Q2
$519K Buy
4,590
+2,140
+87% +$242K 0.01% 635
2018
Q1
$275K Hold
2,450
﹤0.01% 829
2017
Q4
$362K Sell
2,450
-1,700
-41% -$251K ﹤0.01% 790
2017
Q3
$486K Hold
4,150
0.01% 651
2017
Q2
$538K Sell
4,150
-15,190
-79% -$1.97M 0.02% 606
2017
Q1
$2.62M Buy
19,340
+9,670
+100% +$1.31M 0.03% 515
2016
Q4
$1.39M Hold
9,670
0.03% 369
2016
Q3
$1.14M Sell
9,670
-7,400
-43% -$874K 0.03% 405
2016
Q2
$1.81M Buy
17,070
+3,300
+24% +$350K 0.05% 327
2016
Q1
$1.53M Hold
13,770
0.04% 366
2015
Q4
$2.16M Buy
13,770
+10,640
+340% +$1.67M 0.05% 267
2015
Q3
$411K Sell
3,130
-5,140
-62% -$675K 0.01% 678
2015
Q2
$1.44M Buy
8,270
+2,360
+40% +$411K 0.04% 399
2015
Q1
$1.02M Hold
5,910
0.02% 498
2014
Q4
$765K Hold
5,910
0.02% 539
2014
Q3
$760K Sell
5,910
-17,180
-74% -$2.21M 0.02% 543
2014
Q2
$2.04M Buy
23,090
+11,100
+93% +$982K 0.06% 309
2014
Q1
$1.13M Buy
11,990
+690
+6% +$64.9K 0.04% 425
2013
Q4
$1.28M Buy
11,300
+1,400
+14% +$158K 0.05% 362
2013
Q3
$781K Sell
9,900
-5,900
-37% -$465K 0.03% 489
2013
Q2
$1.04M Buy
+15,800
New +$1.04M 0.05% 396